Myocardial Injury for COVID-19 Even in Young Patients with Mild Symptoms

Most young COVID-19 patients not requiring hospitalization showed abnormal cardiac magnetic resonance imaging (CMR) beyond two months after diagnosis.

Injuria miocárdica por COVID-19 incluso en jóvenes y con síntomas leves

Myocardial injury had been found in more serious cases, but not in a healthy population recovered at home.

The increasing evidence of the virus’ capacity to directly affect the heart across the whole population and disease severity spectrum turns our previous article published on March 3 obsolete. In only 5 months, we went from denying myocarditis to saying it is frequent, and that it might even be the norm.

78% of patients in a center in Germany showed abnormal CMR findings 2 to 3 months after testing positive for COVID 19 and despite the fact that 67% of these patients never required hospitalization.


Read also: Infarction, Stroke and Aortic Emergency Syndromes in the Shadow of the Pandemic.


Conventional CMR sequences were used to assess cardiac function, volume, myocardial mass and scars in addition to myocardial mapping in T1 and T2.

The study included 100 patients recovering from the infection (mean age 49) who received high-sensitivity troponin T and CMR testing. A few patients in the group presented traditional risk factors, but only one third was hospitalized and only 2 required mechanical ventilation.

In most patients (78%) troponin was detected at CMR time, even though it had been between 64 and 92 days after diagnosis.


Read also: Temporary Emergency Guidelines for Infarction During the Pandemic.


The publication of this study in JAMA Cardiology has raised many questions that remain unanswered. What should we do with these findings and how long will they persist? Is it necessary to take cardio-protection measures of some kind, with anti-inflammatory or cardiac failure medication?

The answers will come from centers that have already fought the first wave while the rest of us weather the storm.

jamacardiology_puntmann_2020_oi_200057

Original Title: Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19).

Reference: Puntmann VO et al. JAMA Cardiol. 2020; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...